HTG EdgeSeq Reveal
“The data analysis completed on the HTG EdgeSeq Reveal software was provided in a timely fashion, and the report that HTG’s bioinformaticians generated for us was detailed, complete, and easy to understand.”
Dr. Steven A. Porcelli,
Professor and Chair, Department of Microbiology & Immunology,
Weinstock Professor of Microbiology & Immunology,
Scientific Director, Einstein Flow Cytometry Core Facility,
Albert Einstein College of Medicine
A Revolution in Molecular Profiling
Our next-generation sequencing (NGS)-adapted chemistry and instrument platforms automate sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets from samples a fraction of the size required by competitive technologies, enabling customers to do more molecular profiling with less sample.
KOL Luncheon:
Breast Cancer Molecular Diagnostics
Hosted by HTG, the event featured a presentation by Adam Brufsky, MD, PhD (Co-Director, Comprehensive Breast Cancer Center and Medical Director, Woman’s Cancer Center at the UPMC Magee Women’s Hospital, Pittsburgh PA), who discussed the current challenges in diagnosing breast cancer and unmet medical needs and optimizing treatment. Dr. Brufsky answered questions at the conclusion of the event.
HTG Molecular Diagnostics' management team provided an update of their development plan to build a comprehensive breast cancer diagnostic platform. This plan showcased the product roadmap and milestones demonstrating the company’s progresses towards assays that can help clinicians improve the care of cancer patients.
News & Events
American Society of Clinical Oncology (ASCO) 2020
Meet us at our booth 20161!
- Category:
- Future Events
USCAP 2020 Customer Presentation by Dr. Leonie AS Frauenfeld
Presentation Background: Diffuse large B-cell lymphoma (DLBCL) is the most common NHL in adults. Gene expression profiling (GEP) divides DLBCL according to the cell of origin (COO) into three subgroups: GCB, ABC and unclassifiable (UNC), exhibiting different mutational profiles.
- Category:
- Future Events
USCAP 2020 Customer Poster by Dr. Michael J. Hwang
Sarcomatoid Renal Cell Carcinoma Demonstrates an Immunosuppressive Tumor Microenvironment – Implication for Therapeutic Benefit in the Immunotherapy Era
Renal cell carcinoma (RCC) with sarcomatoid features (sRCC) is an aggressive form of RCC with poor response to conventional therapies. Immune checkpoint inhibitors have shown promising therapeutic effect for sRCC in recent small series and sRCC has demonstrated higher PD-L1 expression and PD-1 positive tumor-infiltrating lymphocytes compared to high-grade clear cell RCC (ccRCC). Our aim was to use multiplexed gene expression assays to gain a broader view of the underlying tumor microenvironment in sRCC.
- Category:
- Future Events
HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference
TUCSON, Ariz. , Feb. 19, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the SVB Leerink 9 th Annual
- Category:
- Press Releases
Read the latest news about HTG’s CDx plans and other alliances!
Following End of Qiagen Deal, HTG Molecular to Focus on CDx Plans and Other Alliances
- Category:
- News
Careers at HTG
At HTG Molecular Diagnostics, Inc., we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.
Featured Positions
Sr. Manager, Life Sciences Molecular Testing Laboratory
Database Administrator - Tucson
New Careers
Resources
Find product information, specifications and gene lists here.
Publications
Read white papers or journal publications and view other scientific content.
Support
Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or assays.
Page last updated November 19, 2019
Ready to get started?
HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.